91,000-Patient registry reveals how RA drugs really perform

NCT ID NCT01402661

ENROLLING_BY_INVITATION Knowledge-focused Sponsor: CorEvitas Source: ClinicalTrials.gov โ†—

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This registry follows over 91,000 people with rheumatoid arthritis to see how well approved treatments work and how safe they are in everyday use. Researchers collect data from rheumatologists across North America, including details on disease patterns and other health conditions. The goal is to better understand which treatments are most effective and safe for different patients.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary โ€” we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RHEUMATOID ARTHRITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

psoriatic arthritis rheumatoid arthritis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • CorEvitas, LLC

    Waltham, Massachusetts, 02451, United States